ATE250580T1 - Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie - Google Patents

Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie

Info

Publication number
ATE250580T1
ATE250580T1 AT99934281T AT99934281T ATE250580T1 AT E250580 T1 ATE250580 T1 AT E250580T1 AT 99934281 T AT99934281 T AT 99934281T AT 99934281 T AT99934281 T AT 99934281T AT E250580 T1 ATE250580 T1 AT E250580T1
Authority
AT
Austria
Prior art keywords
benigger
arylpiperazine
treatment
prostate hyperplasia
substituted pyridino
Prior art date
Application number
AT99934281T
Other languages
English (en)
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE250580T1 publication Critical patent/ATE250580T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT99934281T 1998-02-20 1999-02-19 Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie ATE250580T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
ATE250580T1 true ATE250580T1 (de) 2003-10-15

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99934281T ATE250580T1 (de) 1998-02-20 1999-02-19 Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie

Country Status (24)

Country Link
US (1) US6218396B1 (de)
EP (1) EP1054868B1 (de)
JP (1) JP2002503724A (de)
KR (1) KR100591028B1 (de)
CN (1) CN1121390C (de)
AR (1) AR014626A1 (de)
AT (1) ATE250580T1 (de)
AU (1) AU766398B2 (de)
BR (1) BR9909647A (de)
CZ (1) CZ294136B6 (de)
DE (1) DE69911582T2 (de)
DK (1) DK1054868T3 (de)
ES (1) ES2209468T3 (de)
HK (1) HK1030776A1 (de)
HU (1) HUP0100781A3 (de)
IL (2) IL137954A0 (de)
NO (1) NO317103B1 (de)
NZ (1) NZ506462A (de)
PL (1) PL342339A1 (de)
PT (1) PT1054868E (de)
TR (1) TR200003220T2 (de)
TW (1) TW565555B (de)
WO (1) WO1999042448A1 (de)
ZA (1) ZA991315B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1515556A (zh) * 1997-05-12 2004-07-28 ����-������ҩƷ��˾ 用以制备芳基取代哌嗪的中间体化合物
WO2002012190A2 (en) 2000-08-08 2002-02-14 Ortho Mcneil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as h3 receptor ligands
MXPA04006344A (es) * 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventivos/remedios para la perturbacion de miccion.
WO2008050732A1 (fr) * 2006-10-23 2008-05-02 Takeda Pharmaceutical Company Limited Dérivé de l'iminopyridine et son utilisation
UY31781A (es) * 2008-04-23 2009-12-14 Takeda Pharmaceutical Derivados de iminopiridina y su uso
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (en) * 1997-07-15 1999-01-28 Sankyo Company, Limited Piperazine derivatives

Also Published As

Publication number Publication date
EP1054868A1 (de) 2000-11-29
BR9909647A (pt) 2000-11-21
ZA991315B (en) 2000-11-20
CZ20003044A3 (cs) 2001-04-11
TW565555B (en) 2003-12-11
NO317103B1 (no) 2004-08-09
IL137954A (en) 2007-06-03
AU766398B2 (en) 2003-10-16
EP1054868B1 (de) 2003-09-24
DE69911582D1 (de) 2003-10-30
AU3302599A (en) 1999-09-06
DE69911582T2 (de) 2005-09-15
HUP0100781A2 (hu) 2001-08-28
KR20010041115A (ko) 2001-05-15
PL342339A1 (en) 2001-06-04
HUP0100781A3 (en) 2002-12-28
KR100591028B1 (ko) 2006-06-22
NZ506462A (en) 2003-07-25
NO20004141L (no) 2000-10-19
HK1030776A1 (en) 2001-05-18
NO20004141D0 (no) 2000-08-18
JP2002503724A (ja) 2002-02-05
CZ294136B6 (cs) 2004-10-13
WO1999042448A1 (en) 1999-08-26
AR014626A1 (es) 2001-03-28
IL137954A0 (en) 2001-10-31
CN1121390C (zh) 2003-09-17
DK1054868T3 (da) 2003-12-22
US6218396B1 (en) 2001-04-17
PT1054868E (pt) 2004-01-30
TR200003220T2 (tr) 2001-04-20
CN1291188A (zh) 2001-04-11
ES2209468T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69928542D1 (de) 5ht2-agoniste zur behandlung des glaukoms
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
DE69941280D1 (de) Vorrichtung zur Behandlung von Stenosen an Verzweigungen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE300597T1 (de) Behandlung von geweben
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ID27191A (id) Metode untuk pengobatan insomnia
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
DE69905214T2 (de) Mittel zur Behandlung der Osteoporose
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1054868

Country of ref document: EP

REN Ceased due to non-payment of the annual fee